Entries by Rebecca Mercer

New Publication: Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian Provinces

We are excited to share this three-province cost-effectiveness analysis of bevacizumab with first line combination chemotherapy in patients with metastatic colorectal cancer. View the full text at https://journals.sagepub.com/doi/full/10.1177/23814683211021060 Download a PDF copy by Clicking Here Authors: Reka E. Pataky , Jaclyn Beca , David Tran, Wei Fang Dai, Erind Dvorani, (more…)

2021 Canadian Cancer Research Conference – Abstract deadline July 5

The Canadian Cancer Research Conference provides an excellent opportunity to present research to the cancer community. Abstract submissions from the entire spectrum of research topics are welcome. Trainees (undergraduate students, graduate students, and postdoctoral fellows) and new principal investigators are encouraged to present their work.  Call for Abstracts Abstract submissions for (more…)

Terry Fox New Investigator Award

Registration Deadline for Intent to apply: June 25th, 2021. Full Application Deadline: September 10th, 2021 Visit https://www.tfri.ca/funding-opportunities/funding-programs/program/new-investigator-program for full detail and to apply. The Terry Fox New Investigator Awards support outstanding early career researchers as they develop their careers as independent research scientists or clinician-scientists to undertake high-quality cancer research while (more…)

CAPT-ACTP 2021 Scholarships

Visit the CAPT-ACTP Scholarship page here: https://www.capt-actp.ca/scholarship-awards/ 25 years ago, on April 29th, 1996, the first CAPT-ACTP first meeting was held, and the organization was officially formed. To celebrate this milestone in our organization’s history, CAPT-ACTP is pleased to announce the launch of two scholarships to our membership. The CAPT-ACTP (more…)

CCS/CIHR Action Grants: Proof of Concept Interventions in Primary Cancer Prevention

The Canadian Cancer Society (CCS), the Canadian Institutes of Health Research – Institute of Cancer Research (CIHR-ICR), the Canadian Institutes of Health Research – Institute of Indigenous Peoples’ Health (IIPH), and partners have committed approximately $5M over one year to jointly fund up to 25 Proof-of-Concept Grants focused on interventions in Primary Cancer Prevention. Important dates: Registration (more…)

CPAC – Consultant, Health Economics

To view full details and to apply online click here! Closing Date: May 17,2021 The Consultant, Health Economics supports the Cancer Systems, Performance & Innovation Division in carrying out projects and initiatives to achieve organizational priorities. Reporting to the Manager, Health Policy, Measurement and Evaluation and working closely with the Lead, Health Economics, (more…)

PMPRB Report: Alignment Among Public Formularies in Canada, Part 2: Oncology Medicines

Visit https://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/formularies-part2-oncology-medicines.html to read the full report from Canada’s Patented Medicine Pricing Review Board (PMPRB). The current report, Part 2 in the Alignment of Public Formularies in Canada series, addresses the public coverage of oncology medicines reviewed by the Canadian Agency for Drugs and Technologies in Health’s (CADTH) interim Joint Oncology Drug Review (more…)